Eloxx Pharmaceuticals, Inc.

Public companies file this within four business days when something important happens that investors should know about before the next quarterly report.

Eloxx Pharmaceuticals, Inc. filed this to disclose a change in directors or executive officers appointments, departures, or role changes that can signal a strategic shift.